nemtabrutinib
Nemtabrutinib is a drug used to treat Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, and other conditions. Nemtabrutinib is being actively studied in 2 studies; no studies for this drug have been completed so far.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.) | A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 1400) | |
| Merck Sharp & Dohme Corp. | Ankara Universitesi Tip Fakultesi Cebeci Hastanesi ( Site 2400) | |
| Centre Hospitalier Lyon-Sud ( Site 0804) |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Active, not recruiting
- Lymphoma, B-Cell
- +8 more
- Nemtabrutinib
- Scottsdale, Arizona
- +9 more
2022-03-10
Mar 10, 2022M
Recruiting
- Hematologic Malignancies
- Nemtabrutinib
- Hackensack, New Jersey
- +21 more
2022-04-07
Apr 7, 2022